Mangoceuticals (MGRX) Cash from Investing Activities (2023)
Mangoceuticals recorded quarterly Cash from Investing Activities of -$3519.0 in Q1 2023.
Mangoceuticals' Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$3519.0 for Q1 2023.
- In Q1 2023, Cash from Investing Activities changed N/A year-over-year to -$3519.0; the TTM figure through Dec 2023 stood at -$3519.0 (changed N/A YoY), while the FY2024 annual figure was $65000.0, up 1947.12% from the prior year.
- Cash from Investing Activities came in at -$3519.0 for Q1 2023 at Mangoceuticals.
- In the past five years, Cash from Investing Activities ranged from a high of -$3519.0 in Q1 2023 to a low of -$3519.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -167.75 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 747.39 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -13.90 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 48.08 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 137.98 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -112.49 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -1.31 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -26,000.00 |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | -15.87 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -3,519.00 |
| Mar 31, 2023 | -3,519.00 |